Internal Medicine · San Diego, CA
NPI
1629234109
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
200 W Arbor Dr
San Diego, CA, 92103
Phone (800) 926-8273
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
1,940 services
Medicare patients, 2024
167
Average age 74
Drug cost, 2024
$6.2M
662 prescriptions
Company payments, 2025
$403K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hatim Husain was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 688 times for 127 patients. In total Hatim Husain billed 1,940 services in 8 codes, and Medicare paid $136K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 688 | 127 | $13.35 | $9,183 |
| 99215 Office E&M - Established | Facility | 679 | 119 | $114.54 | $78K |
| 99215 Office E&M - Established | Office | 247 | 91 | $147.46 | $36K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 234 | 87 | $13.46 | $3,149 |
| 99205 Office E&M - New | Facility | 33 | 33 | $142.29 | $4,695 |
| 99233 Hospital E&M - Subsequent | Facility | 27 | 20 | $92.49 | $2,497 |
| 99232 Hospital E&M - Subsequent | Facility | 20 | 14 | $62.04 | $1,241 |
By year: 2022 $123K for 1,078 services; 2023 $144K for 1,292 services; 2024 $136K for 1,940 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hatim Husain prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 227 prescriptions and refills. In total Hatim Husain wrote 662 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 227 | 227 | 22 | $3.6M |
| Eliquis Apixaban | 59 | 63 | 12 | $36K |
| Ondansetron Hcl Generic | 32 | 32 | 19 | $164 |
| Prochlorperazine Maleate Generic | 29 | 29 | 20 | $265 |
| Dexamethasone Generic | 28 | 28 | 16 | $335 |
| Retevmo Selpercatinib | 23 | 23 | Under 11 | $496K |
| Gilotrif Afatinib Dimaleate | 22 | 22 | Under 11 | $221K |
| Alecensa Alectinib Hcl | 15 | 15 | Under 11 | $275K |
| Lorbrena Lorlatinib | 14 | 14 | Under 11 | $279K |
| Lidocaine Hcl Viscous Lidocaine Hcl | 12 | 12 | Under 11 | $135 |
| Ondansetron Odt Ondansetron | 12 | 12 | Under 11 | $169 |
| Folic Acid Generic | 12 | 22 | Under 11 | $30.02 |
| Lumakras Sotorasib | 12 | 12 | Under 11 | $250K |
| Oxycodone Hcl Generic | 11 | 11 | Under 11 | $58.27 |
| Vitrakvi Larotrectinib Sulfate | 11 | 11 | Under 11 | $403K |
Brand drugs: 429 claims; generic drugs: 233 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hatim Husain $403K ($403K in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $170K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 100 | $170K |
| Jazz Pharmaceuticals Inc. JAZZ | 52 | $85K |
| Janssen Biotech, Inc. JNJ | 63 | $51K |
| Daiichi Sankyo Inc. 4568.T | 32 | $43K |
| Regeneron Healthcare Solutions, Inc. REGN | 32 | $22K |
| Rigel Pharmaceuticals, Inc. RIGL | 4 | $7,730 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $7,228 |
| Pfizer Inc. PFE | 2 | $4,500 |
| Taiho Oncology, Inc. 4578.T | 1 | $3,500 |
| Regeneron Pharmaceuticals, Inc. REGN | 3 | $2,901 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.